Healthcare provider profile · identity verified

Robert Thomas Perkins, D.O.

Family Practice · PHILADELPHIA, PA · NPI 1366892416

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	682	220
Amlodipine Besylate	Amlodipine Besylate	420	150
Lisinopril	Lisinopril	291	83
Albuterol Sulfate Hfa	Albuterol Sulfate	285	90
Gabapentin	Gabapentin	265	100
Fluticasone Propionate	Fluticasone Propionate	261	118
Metformin Hcl	Metformin Hcl	254	80
Losartan Potassium	Losartan Potassium	220	69
Rosuvastatin Calcium	Rosuvastatin Calcium	215	73
Jardiance	Empagliflozin	185	46
Omeprazole	Omeprazole	173	77
Metoprolol Succinate	Metoprolol Succinate	169	64
Furosemide	Furosemide	165	57
Diclofenac Sodium	Diclofenac Sodium	164	79
Carvedilol	Carvedilol	159	58
Pantoprazole Sodium	Pantoprazole Sodium	158	55
Tamsulosin Hcl	Tamsulosin Hcl	149	54
Levothyroxine Sodium	Levothyroxine Sodium	145	34
Hydrochlorothiazide	Hydrochlorothiazide	144	51
Ibuprofen	Ibuprofen	142	60
Glipizide	Glipizide	124	41
Escitalopram Oxalate	Escitalopram Oxalate	120	30
Naproxen	Naproxen	120	51
Nifedipine Er	Nifedipine	119	42
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	118	37
Trazodone Hcl	Trazodone Hcl	101	41
Clopidogrel	Clopidogrel Bisulfate	95	28
Eliquis	Apixaban	89	25
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	89	34
Ozempic	Semaglutide	88	21
Duloxetine Hcl	Duloxetine Hcl	82	23
Famotidine	Famotidine	81	35
Simvastatin	Simvastatin	81	24
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	76	29
Montelukast Sodium	Montelukast Sodium	76	24
Prednisone	Prednisone	71	53
Hydralazine Hcl	Hydralazine Hcl	69	28
Farxiga	Dapagliflozin Propanediol	68	18
Triamcinolone Acetonide	Triamcinolone Acetonide	65	42
Trulicity	Dulaglutide	64	12
Azithromycin	Azithromycin	63	36
Glipizide Er	Glipizide	63	18
Valsartan	Valsartan	63	22
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	62	22
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	62	21
Metoprolol Tartrate	Metoprolol Tartrate	58	22
Metformin Hcl Er	Metformin Hcl	56	22
Alendronate Sodium	Alendronate Sodium	55	18
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	55	14
Meclizine Hcl	Meclizine Hcl	54	17
Mirtazapine	Mirtazapine	54	27
Meloxicam	Meloxicam	53	34
Allopurinol	Allopurinol	51	13
Oxybutynin Chloride Er	Oxybutynin Chloride	48	24
Potassium Chloride	Potassium Chloride	48	12
Levetiracetam	Levetiracetam	46	suppressed
Pravastatin Sodium	Pravastatin Sodium	46	16
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	45	16
Citalopram Hbr	Citalopram Hydrobromide	45	12
Sertraline Hcl	Sertraline Hcl	45	16
Quetiapine Fumarate	Quetiapine Fumarate	44	12
Tizanidine Hcl	Tizanidine Hcl	44	15
Amitriptyline Hcl	Amitriptyline Hcl	43	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	43	29
Buspirone Hcl	Buspirone Hcl	42	suppressed
Chlorthalidone	Chlorthalidone	41	suppressed
Donepezil Hcl	Donepezil Hcl	41	15
Spironolactone	Spironolactone	41	18
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	41	16
Ciprofloxacin Hcl	Ciprofloxacin Hcl	39	31
Doxepin Hcl	Doxepin Hcl	35	suppressed
Xarelto	Rivaroxaban	35	11
Atenolol	Atenolol	33	12
Irbesartan	Irbesartan	33	11
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	32	suppressed
Bumetanide	Bumetanide	32	13
Finasteride	Finasteride	31	suppressed
Oxycodone Hcl	Oxycodone Hcl	31	suppressed
Rybelsus	Semaglutide	30	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	29	12
Glimepiride	Glimepiride	28	suppressed
Januvia	Sitagliptin Phosphate	28	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	28	suppressed
Seroquel	Quetiapine Fumarate	28	suppressed
Tradjenta	Linagliptin	28	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	28	suppressed
Warfarin Sodium	Warfarin Sodium	28	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	27	26
Baclofen	Baclofen	27	18
Clotrimazole	Clotrimazole	27	suppressed
Nystatin	Nystatin	27	11
Sumatriptan Succinate	Sumatriptan Succinate	27	suppressed
Clobetasol Propionate	Clobetasol Propionate	26	15
Ezetimibe	Ezetimibe	26	13
Methotrexate	Methotrexate Sodium	25	suppressed
Mupirocin	Mupirocin	25	17
Enalapril Maleate	Enalapril Maleate	24	suppressed
Novolog Flexpen	Insulin Aspart	24	suppressed
Humalog Kwikpen U-100	Insulin Lispro	23	suppressed
Alcohol Swabs	Alcohol Antiseptic Pads	22	suppressed
Colchicine	Colchicine	21	12
Klayesta	Nystatin	21	suppressed
Ondansetron Odt	Ondansetron	21	19
Pregabalin	Pregabalin	21	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	20	suppressed
Valacyclovir	Valacyclovir Hcl	20	suppressed
Arnuity Ellipta	Fluticasone Furoate	19	suppressed
Diazepam	Diazepam	19	suppressed
Lidocaine	Lidocaine	19	suppressed
Tramadol Hcl	Tramadol Hcl	19	13
Advair Hfa	Fluticasone Propion/Salmeterol	18	suppressed
Ammonium Lactate	Ammonium Lactate	18	suppressed
Easy Touch Alcohol Prep Pads	Alcohol Antiseptic Pads	18	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	18	suppressed
Memantine Hcl	Memantine Hcl	18	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	17	suppressed
Chlorhexidine Gluconate	Chlorhexidine Gluconate	17	suppressed
Fluconazole	Fluconazole	17	11
Lorazepam	Lorazepam	17	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	17	suppressed
Risperidone	Risperidone	17	suppressed
Spiriva Handihaler	Tiotropium Bromide	17	suppressed
Varenicline Tartrate	Varenicline Tartrate	17	suppressed
Aripiprazole	Aripiprazole	16	suppressed
Divalproex Sodium	Divalproex Sodium	16	suppressed
Glipizide-Metformin	Glipizide/Metformin Hcl	16	suppressed
Letrozole	Letrozole	16	suppressed
Novolin 70-30 Flexpen	Insulin Nph Hum/Reg Insulin Hm	16	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	15	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	15	suppressed
Anastrozole	Anastrozole	14	suppressed
Breztri Aerosphere	Budesonide/Glycopyr/Formoterol	14	suppressed
Clonazepam	Clonazepam	14	suppressed
Loperamide	Loperamide Hcl	14	suppressed
Metronidazole	Metronidazole	14	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	14	suppressed
Linzess	Linaclotide	13	suppressed
Torsemide	Torsemide	13	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	13	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	12	suppressed
Cilostazol	Cilostazol	12	suppressed
Cinacalcet Hcl	Cinacalcet Hcl	12	suppressed
Incruse Ellipta	Umeclidinium Bromide	12	suppressed
Nitroglycerin	Nitroglycerin	12	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	12	12
Polymyxin B Sul-Trimethoprim	Polymyxin B Sulf/Trimethoprim	12	suppressed
Telmisartan	Telmisartan	12	suppressed
Verapamil Sr	Verapamil Hcl	12	suppressed
Breo Ellipta	Fluticasone/Vilanterol	11	suppressed
Dorzolamide-Timolol	Dorzolamide Hcl/Timolol Maleat	11	suppressed
Entresto	Sacubitril/Valsartan	11	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	11	suppressed
Irbesartan-Hydrochlorothiazide	Irbesartan/Hydrochlorothiazide	11	suppressed
Lovastatin	Lovastatin	11	suppressed
Mexiletine Hcl	Mexiletine Hcl	11	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	11	suppressed
Ondansetron Hcl	Ondansetron Hcl	11	suppressed
Solifenacin Succinate	Solifenacin Succinate	11	suppressed
Tacrolimus	Tacrolimus	11	suppressed
Verapamil Er	Verapamil Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error